Q3 2024 · 13F-HR
GREAT POINT PARTNERS LLCholdings as filed
Filed 2024-11-13 · accession 0001172661-24-004656
$339.8M
Reported value
30
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 64135M105 | NGNE | NEUROGENE INC | $42.1M | 12.4% | 1,004,291 | Common | SHARED |
| 00370M103 | ABVX | ABIVAX SA | $24.5M | 7.22% | 2,128,773 | Common | SHARED |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $21.4M | 6.30% | 1,910,121 | Common | SHARED |
| 30052C107 | EOLS | EVOLUS INC | $19.0M | 5.58% | 1,170,000 | Common | SHARED |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $17.1M | 5.02% | 750,000 | Common | SHARED |
| 23282W605 | CYTK | CYTOKINETICS INC | $16.7M | 4.91% | 316,000 | Common | SHARED |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $15.0M | 4.43% | 1,299,503 | Common | SHARED |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $14.8M | 4.35% | 1,326,234 | Common | SHARED |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $13.6M | 4.00% | 6,934,982 | Common | SHARED |
| G9TY5A101 | ZURA | ZURA BIO LTD | $13.3M | 3.90% | 3,263,672 | Common | SHARED |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $12.6M | 3.71% | 514,659 | Common | SHARED |
| N5749R100 | 2GH | MERUS N V | $12.5M | 3.68% | 250,000 | Common | SHARED |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $11.9M | 3.51% | 1,000,000 | Common | SHARED |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $10.2M | 3.01% | 255,000 | Common | SHARED |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $10.2M | 3.00% | 2,811,955 | Common | SHARED |
| M96088105 | URGN | UROGEN PHARMA LTD | $9.6M | 2.84% | 758,786 | Common | SHARED |
| 68404V100 | — | OPTINOSE INC | $8.6M | 2.54% | 12,861,136 | Common | SHARED |
| 03940C100 | ACLXGBX | ARCELLX INC | $8.4M | 2.46% | 100,000 | PUT | SHARED |
| 03940C100 | ACLXGBX | ARCELLX INC | $8.4M | 2.46% | 100,000 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $7.5M | 2.22% | 275,000 | Common | SHARED |
| 69012T305 | OTLK | OUTLOOK THERAPEUTICS INC | $6.9M | 2.03% | 1,293,028 | Common | SHARED |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $6.1M | 1.78% | 322,380 | Common | SHARED |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $5.6M | 1.65% | 959,953 | Common | SHARED |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $5.2M | 1.54% | 500,000 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $5.1M | 1.49% | 1,016,375 | Common | SHARED |
| 90466Y103 | — | UNICYCIVE THERAPEUTICS INC | $3.5M | 1.03% | 8,559,000 | Common | SHARED |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $3.5M | 1.03% | 2,790,698 | Common | SHARED |
| 816212302 | RNAC | CARTESIAN THERAPEUTICS INC | $3.2M | 0.95% | 200,000 | Common | SHARED |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $2.0M | 0.60% | 674,075 | Common | SHARED |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $1.3M | 0.37% | 248,168 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.